Y200-2310 Screening compound: N-(1,3-benzothiazol-2-yl)-2-phenoxyacetamide

Y200-2310 Screening compound: N-(1,3-benzothiazol-2-yl)-2-phenoxyacetamide
Y200-2310 Screening compound: N-(1,3-benzothiazol-2-yl)-2-phenoxyacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-2310
N-(1,3-benzothiazol-2-yl)-2-phenoxyacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-2310

Molecular Formula

C15H12N2O2S (C15 H12 N2 O2 S)

Compound Name

N-(1,3-benzothiazol-2-yl)-2-phenoxyacetamide

IUPAC name

N-(13-benzothiazol-2-yl)-2-phenoxyacetamide

SMILES

O=C(COc1ccccc1)Nc1nc(cccc2)c2s1

InChI

InChI=1S/C15H12N2O2S/c18-14(10-19-11-6-2-1-3-7-11)17-15-16-12-8-4-5-9-13(12)20-15/h1-9H,10H2,(H,16,17,18)

InChI Key

AUTZTNBPWAMWLQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00427774

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

284.34

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.796

Distribution Coefficient, logD

3.796

Water Solubility, LogSw

-4.09

Polar Surface Area

40.377

Acid Dissociation Constant (pKa)

11.28

Base Dissociation Constant (pKb)

3.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.70

Y200-2310 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Antimitotic Tubulin Library (17355 compounds)

Fragments Library (11262 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Epigenetic
Structure:
  • Fragments

References: we are preparing a list of scientific research reports with Y200-2310 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-2310?
Check Price and Availability of Y200-2310, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-2310 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-2310
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-2310
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-2310 available by request